发明名称 1,2-di(cyclic)substituted benzene compounds
摘要 In one aspect, the present invention provides compounds having formula (1) or (100), a salt thereof or a hydrate of the foregoing, which compounds exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and are useful as therapeutic or prophylactic agents for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome; rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R10 represents optionally substituted cycloalkyl, etc., R20-23 represent hydrogen, alkyl, alkoxy, etc., R30-32 represent hydrogen, alkyl, oxo, etc., and R40 represents optionally substituted alkyl, etc.
申请公布号 US7425554(B2) 申请公布日期 2008.09.16
申请号 US20040022702 申请日期 2004.12.27
申请人 EISAI R&D MANAGEMENT CO., LTD. 发明人 KAWAHARA TETSUYA;KOTAKE MAKOTO;YONEDA NAOKI;HIROTA SHINSUKE;OHKURO MASAYOSHI
分类号 A61K31/535;A01N43/40;A01N57/00;A61K31/381;A61K31/382;A61K31/40;A61K31/407;A61K31/4418;A61K31/451;A61K31/452;A61K31/4525;A61K31/495;A61K31/496;A61K31/4965;A61K31/5375;A61K31/5377;A61K31/55;A61P1/00;A61P1/04;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P37/06;A61P37/08;A61P43/00;C07D207/06;C07D207/12;C07D207/273;C07D207/325;C07D211/14;C07D211/16;C07D211/18;C07D211/38;C07D211/42;C07D211/46;C07D211/56;C07D211/58;C07D211/62;C07D211/70;C07D211/72;C07D213/36;C07D213/64;C07D213/75;C07D233/04;C07D241/04;C07D241/18;C07D257/04;C07D261/08;C07D265/30;C07D265/32;C07D271/10;C07D277/28;C07D295/00;C07D295/02;C07D295/03;C07D295/067;C07D295/073;C07D295/08;C07D295/088;C07D295/096;C07D295/12;C07D295/135;C07D295/14;C07D295/15;C07D295/155;C07D295/18;C07D295/205;C07D307/52;C07D309/04;C07D309/14;C07D333/20;C07D335/02;C07D405/12;C07D413/00;C07D413/02;C07D413/12;C07D487/08 主分类号 A61K31/535
代理机构 代理人
主权项
地址